Dongwha's DW166HC likely to be No. 2 new drugs in Korea.

Published: 1999-07-22 11:41:00

Updated: 1999-07-22 11:41:00

SK pharmaceutical obtained the manufacturing licence of a platinum complex preparation as a new drug with passing through the clinical phase II studies only, which was exceptional for an anticancer drug while provisionally requiring phase III studies for an authorization of new drugs.

Article ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK